SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomms reported worldwide, performance-focused layoffs are a key topic, with traders debating whether the cuts signal underperformance or could improve efficiency. Some remain cautious ahead of the upcoming earnings report, while others point to QCOMs relative strength against the semiconductor sector and a possible rebound setup.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSMs sharp selloff is being driven by uncertainty over Auvelitys launch for Alzheimers-related agitation, as prescription growth has not clearly accelerated despite the expanded sales effort. Traders are split between concerns about a slow rollout, sales execution and delayed profitability, and the view that samples and long-term-care channels may be understating uptake; the Q3 report is widely seen as the key test.

Surrozen, Inc. is a clinical stage biotechnology company, which engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.

Surrozen Inc

Mercks BRUNELLO results on Wnt-pathway treatment have fueled attention by providing clinical support for a mechanism used in Surrozens experimental eye drugs, though Surrozens own efficacy in patients remains unproven. Traders also point to FDA clearance for SZN-8141 and the resulting financing, while debating whether the sharp share move reflects fundamental validation or speculative momentum and dilution concerns.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarnas steep selloff after earnings and a weaker outlook, including softness in Germany, dominates discussion. Traders are frustrated by persistent price weakness, with some blaming shorting or manipulation, while bullish holders argue the decline is overdone given growth partnerships such as Apple and JPMorgan and the companys longer-term prospects.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Unconfirmed takeover speculation, particularly reported interest from Lundbeck, is driving much of the discussion; traders debate whether a deal is plausible after Xeris reportedly said it is not for sale. Others focus on Recorlevs growth and XP-8121s planned Phase 3 progress as reasons to value the company on its own.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Speculation that regulators may temporarily allow compounding pharmacies to sell certain peptides is a major focus, with bullish traders viewing potential peptide offerings as a growth opportunity. The reaction is divided: many expect a catalyst, while others point to HIMS repeated struggles to break out of its trading range and remain cautious about regulatory scrutiny and profitability.

Alaska Air Group, Inc. is a holding company, which engages in the provision of air transportation services. It operates through the following segments: Alaska Airlines, Hawaiian Airlines, and Regional. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo. The Hawaiian Airlines segment refers to scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. The Regional segment consists of Horizon's and other third-party carriers’ scheduled air transportation on E175 aircraft for passengers under CPAs. The company was founded in 1985 and is headquartered in Seattle, WA.

Alaska Air Group Inc.

Surging jet-fuel costs tied to the Iran conflict are weighing on Alaska Airs outlook, with traders reacting to deeper expected losses and suspended or reduced earnings guidance. Bulls point to resilient travel demand and international expansion, while bears argue fuel expenses could keep squeezing margins.

American Airlines Group, Inc. is a holding company, which engages in the operation of a network carrier through its principal wholly owned mainline operating subsidiary, American. The firm offers air transportation for passengers and cargo. It operates through the following geographical segments: Domestic, Latin America, Atlantic, and Pacific. The company was founded on December 9, 2013, and is headquartered in Fort Worth, TX.

American Airlines Group Inc

American Airlines quarterly results and weaker profit outlook are drawing attention: record revenue and strong premium demand are being overshadowed by elevated jet-fuel costs and expectations of losses. Traders are divided between those looking for a rebound if fuel prices ease and those concerned about squeezed margins and the companys debt burden.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is in focus amid a sharp pullback in the Nasdaq and technology shares, with traders citing hotter inflation, higher-rate concerns, and doubts about AI spending as sources of pressure. The community is split between dip buyers expecting an oversold bounce and bearish traders who see further downside risk in the leveraged fund.

JD.com, Inc. is a technology-driven E-commerce company, which engages in the sale of electronics products and general merchandise products, including audio, video products, and books. It operates in the following segments: JD Retail, JD Logistics, and New Businesses. The JD Retail segment offers online retail, online marketplace, and marketing services. The JD Logistics segment includes internal and external logistics businesses. The New Businesses segment is composed of JD Property, Jingxi, overseas businesses and technology initiatives. The company was founded on June 18, 1998, by Qiang Dong Liu and is headquartered in Beijing, China.

JD.com Inc - ADR

JDs earnings have sparked a sharp selloff despite stronger profitability and logistics growth, as traders focus on declining revenue and concerns about weak Chinese consumer demand and e-commerce competition. Bulls argue the results show improving margins and cash generation and view the drop as excessive, while bears see the revenue contraction as evidence of ongoing pressure on the business.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
